At Pharmahungary Group we are monitoring the current COVID-19 regulations closely in order to ensure health and safety of family, friends, and colleagues as best we can as well as to continue business operations.
Precautionary measures taken – operations continue without disruption
We have established important measures through our business continuity planning to ensure that we continue to provide the best service to our partners while keeping our staff and partners safe:
1. All visitors are advised to re-organize personal visits to online communications, e.g. Skype, Zoom meetings. Pharmahungary Group has increased availability for online meetings during the current situation. Contact us today to schedule your online meeting!
2. We have trained most of our employees for home-office work where possible and have recently tested our IT system robustness. All facilities have the necessary IT infrastructure as well as minimally required personnel available to continue providing our innovative preclinical and clinical R&D services as well as to further develop our novel in-house R&D projects.
We hope that the current situation will lead decision makers to prioritize investments in health sciences, especially pharmaceutical and biotechnology innovations.
Please do not hesitate to let us know in case you have any questions or might need some additional information on Pharmahungary Group innovative preclinical and clinical R&D services.